3D Printed Microfluidic Devices for Biomarker Analysis ID: 2020-025
This technology represents a significant advancement in the field of biomarker analysis, integrating solid-phase extraction and fluorescent labeling into a single, efficient process.
Photo by starlineart - stock.adobe.com
Technology Overview
The technology involves the use of 3D printed microfluidic devices designed for the solid-phase extraction (SPE) and fluorescent labeling of peptides and proteins. These devices utilize a novel lauryl methacrylate-based monolith, optimized for the retention and processing of preterm birth (PTB) biomarkers. The integration of SPE and fluorescent labeling processes within these devices offers a streamlined approach to biomarker analysis, demonstrating notable efficiency and versatility in handling biomolecules of varying hydrophobicities and masses.
Key Advantages
- Simplification and miniaturization of assay components
- Rapid and customizable fabrication of devices
- Efficient sample preparation, labeling, and concentration of biomolecules
- Ability to process a wide variety of biomolecules, from small peptides to large proteins
Problems Addressed
- Complexity and inefficiency in traditional biomarker analysis methods
- Limited versatility in handling biomolecules of different properties
- High costs and lengthy processes associated with conventional assay component fabrication
Market Applications
- Research and development in the field of biomarker analysis
- Clinical diagnostics, especially for conditions like preterm birth
- Customizable tools for biological and chemical research
- Development of rapid and reliable diagnostic assays
Additional Information
Technology ID: 2020-025
Sell Sheet: Download the Sell Sheet here
Market Analysis: Contact us for a more in-depth market report
Date Published: 28 March, 2025
Connect with the Tech Transfer to:
- Meet with the technology manager
- Receive additional information
- Request a marketing plan report